Search clinical trials for: GH release

Total 61732 results

Solstice Neurosciences

Completed

A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

Drooling

United States
Allergan

Completed

A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

Overactive Bladder

Poland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
Novartis Pharmaceuticals

Completed

Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. (Passion I)

Non-functioning Pituitary Adenoma

Brazil
University of Roma La Sapienza

Completed

Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM) (DREAM)

Secondary Adrenal Insufficiency | Primary Adrenal Insufficiency

Italy
Ipsen

Completed

Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly

Acromegaly

France, Germany, Spain, Belgium, Russian Federation, United Kingdom, Italy, Lithuania, Czechia, Romania, Poland, Netherlands
Medy-Tox

Completed

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

Hyperhidrosis | Anhidrotic Area

Korea, Republic of
Imam Abdulrahman Bin Faisal University

Unknown

Joints Mobilization Versus Myofascial Release on Diabetic Patients With Painful Heel

Diabetic Foot | Plantar Fasciitis

Saudi Arabia
Nationwide Children's Hospital

Completed

Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study

Adrenal Insufficiency | Osteopenia, Osteoporosis | Steroid Suppression of ACTH Secretion

United States
Allergan

Completed

An Adult Spasticity Registry of OnabotulinumtoxinA Treatment (ASPIRE)

Muscle Spasticity

Spain, Italy, United States, Germany, United Kingdom, Taiwan, France
Halozyme Therapeutics

Completed

A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20) (HALO-117-406)

Type 1 Diabetes Mellitus

United States
Ipsen

Completed

Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly (LANTERN)

Acromegaly

China
St Joseph University, Beirut, Lebanon

Completed

Hyperhydrosis Treatment Using Botulinum Toxin

Hyperhidrosis

Lebanon
Ipsen

Completed

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Gastroenteropancreatic Neuroendocrine Tumor

United States
University Hospital of North Norway
The Royal Norwegian Ministry of Health; Hidrosis Clinic, Stockholm, Sweden

Completed

Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa

Hidradenitis Suppurativa

Norway
Providence Health & Services
Aduro Biotech, Inc.

Completed

Phase I Study of Safety and Immunogenicity of ADU-623

Brain Tumor | Glioblastoma Multiforme | Anaplastic Astrocytoma | Astrocytic Tumors

United States
The University of Texas Health Science Center,...
The Center for Clinical and Translational Sciences (CCTS) Clinical Research...

Completed

Effects of Antidiabetic Medications on the Postprandial State in Prediabetes

Obesity | Prediabetes

United States
DeNova Research

Terminated

Safety and Efficacy of the Use of Botox on Acne

Acne Vulgaris

United States
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation (ARTIST)

Polycystic Ovary Syndrome

Germany
University Hospital, Ghent

Completed

Infiltration of the Vestibulum Vaginae With Botulin Toxin in Patients With Localized Provoked Vulvodynia (VVS-01)

Localized Provoked Vulvodynia

Belgium
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease

Cushing's Disease

Italy, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
Tocagen Inc.

Completed

A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma

Glioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Elcelyx Therapeutics, Inc.

Completed

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Type 2 Diabetes Mellitus

United States, Puerto Rico
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly (PAOLA)

Acromegaly

United States, Italy, Belgium, Saudi Arabia, Spain, France, Germany, Canada, United Kingdom, Colombia, Brazil, Israel, Turkey, Romania, Norway, Poland, Russian Federation, Argentina
Golo

Completed

GOLO Open-Label Pilot 1

Diabetes Mellitus, Type II

United States
Merz Pharmaceuticals GmbH

Completed

Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions (SIAXI)

Parkinson's Disease | Traumatic Brain Injury | Chronic Troublesome Sialorrhea | Post-stroke

Germany, Poland
Carl Swartling

Unknown

Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis

Hyperhidrosis

Sweden
Allergan

Completed

Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium

Urinary Incontinence

Belgium
AstraZeneca

Completed

Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects

Type 2 Diabetes Mellitus

United Kingdom
Sun Yat-sen University

Unknown

Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy

Nasopharyngeal Carcinoma

China
University of Pennsylvania

Terminated

Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas (LAR)

Gonadotroph Adenomas

United States
Astellas Pharma Inc

Completed

A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection (OSAKA)

Kidney Transplantation

Belgium, France, Germany, Italy, Spain, Greece, Switzerland, United Kingdom, Ireland, South Africa, Romania, Sweden, Russian Federation, Austria, Hungary, Poland, Portugal, Netherlands, Argentina, Czechia, Norway, Slovakia
GlaxoSmithKline

Completed

Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers

Diabetes Mellitus, Type 2
Seoul National University Hospital

Completed

GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

Polycystic Ovary Syndrome | Infertility

Korea, Republic of
The Adelaide and Meath Hospital, incorporating...

Unknown

Optimising Steroid Replacement in Patients With Adrenal Insufficiency

Adrenal Insufficiency

Ireland
GlaxoSmithKline

Completed

First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050

Diabetes Mellitus, Type 2

United States
Astellas Pharma Inc

Completed

A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids (ADVANCE)

Kidney Transplantation

Belgium, France, Italy, Sweden, Switzerland, Spain, Portugal, Russian Federation, Germany, Korea, Republic of, Czechia, Slovakia, Australia, Hungary, Netherlands, Romania, Estonia, Latvia, Mexico, Lithuania, Poland, Colombia, Finland, Norwa...
AstraZeneca
Parexel

Completed

A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

Type 2 Diabetes Mellitus

United States
Presidio Ospedaliero Garibaldi-Centro

Completed

Botulinum Toxin for Cramps in Diabetic Neuropathy

Diabetes Mellitus | Muscle Cramps Aggravated
University of California, Davis

Completed

The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis

Hyperhidrosis

United States
Cedars-Sinai Medical Center
Abbott

Withdrawn

Testosterone Therapy in Heart Failure

Heart Failure | Hypogonadism
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly

Acromegaly

United States, Germany, Italy, Belgium, Taiwan, Turkey, Switzerland, Israel, Netherlands, Sweden, United Kingdom, Korea, Republic of, Spain, France, Canada, Greece, Russian Federation, Denmark, Mexico, China, Hungary, Norway, Argentina and more
GlaxoSmithKline

Terminated

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

Diabetes Mellitus, Type 2

Australia
Diurnal Limited
National Institutes of Health (NIH)

Completed

Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH

Congenital Adrenal Hyperplasia | Adrenal Insufficiency | Endocrine Disease

United States
University Hospital, Basel, Switzerland
Merck Serono International SA

Completed

Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression (Pergoveris)

Complications Associated With Artificial Fertilization | Female Infertility Due to Nonimplantation of Ovum

Switzerland
Massachusetts General Hospital
National Institute on Aging (NIA)

Unknown

The Effects of Aging and Estrogen on the Pituitary

Healthy

United States
GL Pharm Tech Corporation

Completed

Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg

Healthy

Korea, Republic of
GL Pharm Tech Corporation

Completed

Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg

Healthy

Korea, Republic of
McGill University Health Centre/Research Institute...
CHU de Quebec-Universite Laval

Unknown

Circulating Extracellular Vesicles Released by Human Islets of Langerhans

Type2 Diabetes | Islet Cell Transplantation | Type1 Diabetes Mellitus

Canada
National Cancer Institute (NCI)

Completed

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

Hereditary Leiomyomatosis and Renal Cell Cancer | Cutaneous Leiomyomas

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions

Type II Diabetes

Search clinical trials for: GH release

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations